1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 11 MAY 2015

Key Pharma News 11 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 33 pages

Industry Trend Analysis - EpiTherapeutics Acquisition Will Be Start Of Oncology Deals For Gilead In 2015
Industry Brief - OncoGenex Regains Rights To Custirsen From Teva
Industry Trend Analysis - Celgene's Haematology Expertise Will Benefit AstraZeneca
Industry Brief - Curadev/Roche Enter Cancer Immunotherapy Deal
Industry Brief - Innate/AstraZeneca To Co-Develop IPH2201 In Immuno-Oncology
Industry Trend Analysis - ViiV To Help GSK Weather A Tumultuous 2015
Industry Trend Analysis - Gilead Positioned To Make Key Acquisition
Industry Trend Analysis - GSK Oncology Additions To Increase Novartis' Growth Trajectory
Industry Trend Analysis - Biogen Will Continue To Gain Share Of MS Market
Industry Trend Analysis - Esbriet Sales Will Reach Blockbuster Status In 2016
Industry Brief - Teva Completes Acquisition Of Auspex Pharmaceuticals
Industry Trend Analysis - Outcome Of Perrigo-Mylan-Teva Tussle Will Shape The Generic Industry
Industry Trend Analysis - Diversification To Bolster Celgene's Revenues
Industry Trend Analysis - Tecfidera Will Be Leading MS Drug In 2015
Industry Brief - FDA Approves Ionsys For Acute Postoperative Pain
Industry Brief - Xarelto Gains Approval For Additional Indications In China
Industry Brief - Daiichi Sankyo's Once-Daily Lixiana Receives Positive CHMP Opinion
Industry Brief - FDA Approves Breo Ellipta For Asthma
Industry Brief - FDA Accepts Zinbryta BLA For MS
Industry Brief - Merrimack Completes NDA Submission To FDA For MM-398 In MPC
Industry Brief - Pernix Launches Zohydro ER With BeadTek
Industry Brief - Cresemba Launched In US For Invasive Aspergillosis/Mucormycosis
Industry Brief - Pomalyst Meets Accelerated Approval Requirements For r/r MM
Industry Brief - Vanda Receives Positive CHMP Opinion On Hetlioz For Non-24
Industry Brief - CHMP Adopts Positive Opinion On Opdivo For Advanced Melanoma
Industry Brief - Lilly's Cyramza Gains Fourth FDA Approval
Industry Trend Analysis - Generic Drug Pricing Investigation Unlikely To Produce Results Soon
Industry Trend Analysis - US Generic Aripiprazole Competition Will Stress Otsuka's Reliance On Brexpiprazole
Industry Brief - FDA Grants Opdivo Priority Review For Previously Untreated Advanced Melanoma
Industry Brief - Baxter Seeks EU Approval For MM-398 In Post-Gemcitabine MPC
Industry Trend Analysis - FDA Will Continue To Face Criticism Until Interchangeability And Naming Issues Are Resolved
Industry Trend Analysis - Gilead/AbbVie To Eradicate Niche Commercial Opportunities In HCV
Industry Trend Analysis - BMS To Retain Dominant Position In First-Line Advanced Melanoma Setting
Industry Brief - Follow-Up Announcement Made On Preliminary Findings From Lurasidone Phase III Study
Industry Trend Analysis - Oncolytic Immunotherapy Will Enter The Market In 2015
Industry Trend Analysis - GSK's Shingles Vaccine To Erode Sales Of Merck's Zostavax
Industry Brief - Arzerra Phase III Study Meets Primary Endpoint Of PFS In Relapsed CLL
Industry Brief - Single-Dose Dalvance Meets Primary/Secondary Endpoints In Phase III Study For ABSSSIs

Table Of Contents

Key Pharma News 11 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

The future of the Health Facility Industry in the US

  • February 2017
    9 pages
  • Health Facility  

    Nursing Home  

  • United States  

View report >

Opioid Market in the US

  • February 2017
    4 pages
  • Opioid  

  • United States  

View report >

Opioid Market in the US

  • February 2017
    4 pages
  • Opioid  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.